Oncology

Patients with high-risk, BRCA-positive breast cancer receiving the PARP inhibitor olaparib after standard treatment continue to experience significant survival benefits, according to 6-year follow-up results from the Phase III OlympiA trial.

Socioeconomic barriers and medical distrust hindered COVID-19 vaccine completion among cancer survivors, a high-risk group for severe outcomes from the virus, according to a recent study.

Over the past 45 years, cancer prevention and screening interventions have averted nearly 6 million deaths from major cancers in the United States, according to new research.

Emerging data highlights a critical complication for patients with metastatic lung cancer undergoing treatment with immune checkpoint inhibitors (ICIs), including PD-1 and PD-L1 blockers.

Patients with cancer vaccinated against COVID-19 within 6 months before infection showed significantly higher survival rates, according to a new analysis from the ASCO COVID-19 Registry.

Agricultural pest management methods were explored in a new study to determine how they can be adapted to combat cancer treatment resistance.

Glucose restriction in the tumor microenvironment helps cancer cells survive chemotherapy by altering key metabolic pathways, reveals a new study.

A recent analysis of the IDEAL clinical trial highlights a breakthrough for early-stage breast cancer.